Current Status of Proteomics of Esophageal Carcinoma.

about

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model.Contribution of dysregulated circRNA_100876 to proliferation and metastasis of esophageal squamous cell carcinoma

P2860

Q41593187-65272468-AB43-4D26-B158-15691DD0729D Q58698699-CFAC1E07-0EE5-4385-ADCE-0794517D78D0

P2860

Current Status of Proteomics of Esophageal Carcinoma.

Item

http://www.wikidata.org/entity/Q38966421

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Current Status of Proteomics of Esophageal Carcinoma.

@en

type

Item

label

Current Status of Proteomics of Esophageal Carcinoma.

@en

prefLabel

Current Status of Proteomics of Esophageal Carcinoma.

@en

P1476

Current Status of Proteomics of Esophageal Carcinoma.

@en

P2093

Norihisa Uemura

http://www.w3.org/2001/XMLSchema#string

Tadashi Kondo

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis

Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Cell signaling by receptor tyrosine kinases

Global cancer statistics, 2012

Drug discovery: a historical perspective

The future of immune checkpoint therapy

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

P31

scholarly article

P356

10.1080/14789450.2016.1242418

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27678273

http://www.w3.org/2001/XMLSchema#string

Current Status of Proteomics of Esophageal Carcinoma.

about

P2860

P2860

Current Status of Proteomics of Esophageal Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698